Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01150461 · ClinicalTrials.gov registry record · Phase 2
Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy
A Phase 2 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT01150461: Completed Phase 2 study, sponsored by Massachusetts General Hospital.
NCT01150461 is a Phase 2 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01150461, a Phase 2 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether taking losartan helps people with hypertrophic nonobstructive cardiomyopathy feel better by decreasing the amount of heart muscle thickening and/or the amount of heart muscle scarring.
Interventions
- DRUG placebo
- DRUG losartan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2007-02 |
| Est. Completion | 2010-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01150461
The ClinicalTrials.gov registry entry for NCT01150461 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01150461 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01150461 about?
NCT01150461 is a clinical study titled "Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy". The purpose of this study is to determine whether taking losartan helps people with hypertrophic nonobstructive cardiomyopathy feel better by decreasing the amount of heart muscle thickening and/or the amount of heart muscle scarring.
What is the current status of trial NCT01150461?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2007-02. Estimated completion is 2010-07.
What interventions are being tested in trial NCT01150461?
The interventions under investigation include: placebo (DRUG), losartan (DRUG).
Who is sponsoring clinical trial NCT01150461?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.